CPE also prevents the downregulation of the Mas1/AKT1/eNOS pathway, enhancing the vasorelaxant effect through NO production and avoiding endothelial dysfunction in arteriole in the remanent functional kidney. The gene discussed is MAS1; the disease is endothelial dysfunction.